jcp quiz

Quizzes

Quiz

Quiz: Impact of Clinical Care Pathways in NSCLC

03/11/2022

True or False: The implementation of clinical care pathways results in improved survival for patients diagnosed with NSCLC.

True or False: The...

03/11/2022

Journal of Clinical Pathways

Quiz

Quiz: Cost of Biosimilar Neutropenia Prophylaxis for Pancreatic Cancer

03/10/2022

True or False: Conversion to biosimilar pegfilgrastim-cbqv for chemotherapy-induced neutropenia and febrile neutropenia prophylaxis can generate cost-savings for patients with metastatic pancreatic cancer.

True or False: Conversion to...

03/10/2022

Journal of Clinical Pathways

Sponsored

QUIZ by Sanofi

Quiz: Assessing the Risk of Tumor Lysis Syndrome

03/08/2022

Test your knowledge with this engaging 5 question quiz exploring the risk of tumor lysis syndrome among patients receiving anticancer therapies.

Test your knowledge with this...

03/08/2022

Journal of Clinical Pathways

Quiz

Quiz: Cost-Effectiveness of Opportunistic Salpingectomy for Ovarian Cancer Prevention

02/24/2022

True or False: Opportunistic salpingectomy at the time of elective cholecystectomy is not a cost-effective strategy to prevent ovarian cancer among average risk women.

True or False: Opportunistic...

02/24/2022

Journal of Clinical Pathways

Quiz

Quiz: Risk of Infusion Reactions in Patients With CLL Receiving Obinutuzumab

02/22/2022

True or False: Using chlorambucil before obinutuzumab and using a slow initial obinutuzumab infusion rate may reduce risk of infusion reactions in patients with CLL.

True or False: Using...

02/22/2022

Journal of Clinical Pathways

Quiz

Quiz: Cost-Efficiency of Biosimilar Intravenous Trastuzumab-dkst for Metastatic Breast Cancer

02/17/2022

True or False: Biosimilar intravenous (IV) trastuzumab-dkst is cost-efficient over reference IV and subcutaneous trastuzumab in metastatic breast cancer.

True or False: Biosimilar...

02/17/2022

Journal of Clinical Pathways

Quiz

Quiz: Cost-Effective Treatment Strategy for Gynecologic Cancer

02/15/2022

True or False: Gene-specific surveillance and preventative strategies are cost-effective measures for reducing gynecologic cancer risk in women with Lynch syndrome.

True or False: Gene-specific...

02/15/2022

Journal of Clinical Pathways

Sponsored

QUIZ by Sanofi Genzyme

Quiz: Metastatic castration-resistant prostate cancer

02/11/2022

Test your knowledge with this 5 question quiz exploring the treatment of patients with metastatic castration-resistant prostate cancer.

Test your knowledge with this 5...

02/11/2022

Journal of Clinical Pathways

Quiz

Quiz: Educating Patients With Pancreatic Cancer About Treatment Options

02/10/2022

True or False: Patients with pancreatic cancer infrequently hear about treatment complications and alternatives, while frequently hearing about logistics and potential outcomes.

True or False: Patients with...

02/10/2022

Journal of Clinical Pathways

Quiz

Quiz: Ensartinib vs Crizotinib for ALK-Positive NSCLC

02/01/2022

True or False: Ensartinib demonstrates superior efficacy to crizotinib for patients with advanced ALK-positive NSCLC.

True or False: Ensartinib...

02/01/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Quizzes

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products